Afiniti Appoints Hassan Afzal as Its Chief Executive Officer
전체 맥락을 이해하기 위해서는 본문 보기를 권장합니다.
"I am looking forward to leading this great company and leveraging the strength of our people, culture and our customer-centric focus," said Mr. Afzal. "As a pioneer in using artificial intelligence technology to measurably optimize customer interactions, Afiniti has an exciting opportunity to deploy more intelligence and automation within the customer experience. I will work with Larry and the Board on a seamless transition and thank Larry for his guidance over the last two years."
"Hassan has brought a wealth of experience with excellent strategic and leadership skills to Afiniti, and we are delighted that he will be our Chief Executive Officer," said Mr. Babbio. "He has impressed the Board with the impact he has made at Afiniti, where he has brought a strong client-centric mindset and creative technology leadership. The Board believes his leadership skills and experience will lead Afiniti through its next strategic phase."
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
WASHINGTON -- Businesswire -- Afiniti, the leading provider of AI-enabled enterprise behavioral pairing solutions for customer interactions, has announced the appointment of Hassan Afzal as Afiniti’s Chief Executive Officer and Board Director.
Mr. Afzal, an experienced business leader, will succeed Larry Babbio, who assumed the position of Chief Executive Officer of Afiniti in 2021. His appointment is the culmination of a CEO succession plan and subsequent search process undertaken by the Board. The Board of Directors is grateful to Mr. Babbio for his unwavering commitment to Afiniti and is pleased that the company will continue to benefit from his experience as he will remain with Afiniti as a Board Director.
Mr. Afzal joined Afiniti in 2007 as one of its first employees and has served as its Chief Technology Officer, making him a key architect of Afiniti’s unique and patented technology. He has been a core enabler of Afiniti’s growth to its current scale of about 1,500 employees across 20 countries. Mr. Afzal holds a MSc in Computer and Information Systems from the University of Pennsylvania and a BSE in Electrical Engineering from the University of Virginia.
“I am looking forward to leading this great company and leveraging the strength of our people, culture and our customer-centric focus,” said Mr. Afzal. “As a pioneer in using artificial intelligence technology to measurably optimize customer interactions, Afiniti has an exciting opportunity to deploy more intelligence and automation within the customer experience. I will work with Larry and the Board on a seamless transition and thank Larry for his guidance over the last two years.”
“Hassan has brought a wealth of experience with excellent strategic and leadership skills to Afiniti, and we are delighted that he will be our Chief Executive Officer,” said Mr. Babbio. “He has impressed the Board with the impact he has made at Afiniti, where he has brought a strong client-centric mindset and creative technology leadership. The Board believes his leadership skills and experience will lead Afiniti through its next strategic phase.”
About Afiniti
Afiniti uses patented artificial intelligence technology to pair participants in customer interactions based on how well they are likely to interact. Its technology is used globally in the healthcare, telecommunications, travel, hospitality, insurance, and banking industries, and across multiple customer experience channels. To learn more, visit www.afiniti.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230927105063/en/
이 뉴스는 기업·기관·단체가 뉴스와이어를 통해 배포한 보도자료입니다.
출처:Afiniti
보도자료 통신사 뉴스와이어(www.newswire.co.kr) 배포
Copyright © 뉴스와이어. 무단전재 및 재배포 금지.
- 삼성물산, 아파트 세대 현관까지 음식 배달 로봇 확장 운영 - 뉴스와이어
- 제12회 인터내셔널 슈퍼퀸 모델 콘테스트·제7회 월드 슈퍼퀸 한복 모델 결선대회 성료 - 뉴스와
- 정미소, 국내 최초 ‘저당 두바이 쫀득쿠키’ 출시 - 뉴스와이어
- 해양쓰레기로 만드는 가야금과 사자탈… 서울남산국악당, 겨울방학 ‘우리가족 국악캠프’ 개
- 삼익제약, GDWEB 디자인 어워드 ‘제약·바이오 WEB 부문 그랑프리’ 수상 - 뉴스와이어
- 동아제약, 여드름 압출 후 상처에 의한 2차 감염 치료제 ‘노스카딘겔’ 출시 - 뉴스와이어
- LG CNS, 차바이오텍에 전략적 투자… AI 헬스케어 사업 본격화 - 뉴스와이어
- SRC재활병원-삼성서울병원, 진료 협력 간담회 성료… 식도암 환자 재활 연계 강화 - 뉴스와이어
- 녹십자수의약품 ‘한개한개 챌린지’ 실험종료 비글 위해 약품 1000개 기부 - 뉴스와이어
- TUMI, 2026년 말의 해 기념 한정판 컬렉션 출시 - 뉴스와이어